Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale President and CEO sold 15,152 shares at $12.98 ($196,673)
  8. 4 Planned sale Director sold 2,860 shares at $13.95 ($39,897)
  9. 4 Grant or award President and CEO acquired 50,000 shares (grant or award)
  10. 4 Open-market buy 10% owner bought 520 shares at $10.60 ($5,512)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
  13. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
  14. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
  15. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
  16. 4 Grant or award Director acquired 207,100 shares (grant or award)
  17. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
  18. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
  19. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
  20. 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)

Page 2 of 18 · 354 filings